Open AccessPharmacoeconomic analysis of using cyclin-dependent kinase 4 and 6 inhibitors in the first line treatment of HR-positive HER2-negative advanced breast cancer
Author(s) -
N. А. Avxentyev,
Е. В. Лубенникова,
M. Yu. Frolov
Publication year - 2020
Publication title -
farmakoèkonomika
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.177
H-Index - 3
eISSN - 2070-4933
pISSN - 2070-4909
DOI - 10.17749/2070-4909.2019.12.4.279-290
Subject(s) - breast cancer , her2 negative , cyclin dependent kinase 4 , oncology , medicine , kinase , cancer research , cancer , chemistry , metastatic breast cancer , cyclin dependent kinase 2 , biochemistry , cell cycle